BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23180161)

  • 1. The liver X receptor agonist T0901317 protects mice from high fat diet-induced obesity and insulin resistance.
    Gao M; Liu D
    AAPS J; 2013 Jan; 15(1):258-66. PubMed ID: 23180161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol suppresses T0901317-induced hepatic fat accumulation in mice.
    Gao M; Liu D
    AAPS J; 2013 Jul; 15(3):744-52. PubMed ID: 23591747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
    Gao M; Bu L; Ma Y; Liu D
    PLoS One; 2013; 8(6):e65641. PubMed ID: 23762402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired adipose expansion caused by liver X receptor activation is associated with insulin resistance in mice fed a high-fat diet.
    Dong Y; Xu Z; Zhang Z; Yin X; Lin X; Li H; Zheng F
    J Mol Endocrinol; 2017 Apr; 58(3):141-154. PubMed ID: 28258092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.
    Zheng F; Zhang S; Lu W; Wu F; Yin X; Yu D; Pan Q; Li H
    PLoS One; 2014; 9(6):e101269. PubMed ID: 24972069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.
    van Straten EM; van Meer H; Huijkman NC; van Dijk TH; Baller JF; Verkade HJ; Kuipers F; Plösch T
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1171-8. PubMed ID: 19724022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor agonist T0901317 reduces neuropathological changes and improves memory in mouse models of experimental dementia.
    Sodhi RK; Singh N
    Eur J Pharmacol; 2014 Jun; 732():50-9. PubMed ID: 24690259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
    J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development.
    van der Stoep M; Li Z; Calpe-Berdiel L; van der Sluis RJ; Saleh P; McKinnon HJ; Smit MJ; Korporaal SJ; Van Berkel TJ; Van Eck M; Hoekstra M
    Biochem Pharmacol; 2013 Dec; 86(11):1594-602. PubMed ID: 24095721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
    Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
    J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of pregnane X receptor by pregnenolone 16 α-carbonitrile prevents high-fat diet-induced obesity in AKR/J mice.
    Ma Y; Liu D
    PLoS One; 2012; 7(6):e38734. PubMed ID: 22723881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-sensitizing effect of LXR agonist T0901317 in high-fat fed rats is associated with restored muscle GLUT4 expression and insulin-stimulated AS160 phosphorylation.
    Baranowski M; Zabielski P; Błachnio-Zabielska AU; Harasim E; Chabowski A; Górski J
    Cell Physiol Biochem; 2014; 33(4):1047-57. PubMed ID: 24732673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danning tablets alleviate high fat diet-induced obesity and fatty liver in mice via modulating SREBP pathway.
    Ma Y; Li J; Ju Z; Huang W; Wang Z; Yang L; Ding L
    J Ethnopharmacol; 2021 Oct; 279():114320. PubMed ID: 34116189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
    Sato K; Kamada T
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb; 158(2):201-6. PubMed ID: 21056113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlorogenic acid improves high fat diet-induced hepatic steatosis and insulin resistance in mice.
    Ma Y; Gao M; Liu D
    Pharm Res; 2015 Apr; 32(4):1200-9. PubMed ID: 25248334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
    Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palmitic acid-induced apoptosis in pancreatic β-cells is increased by liver X receptor agonist and attenuated by eicosapentaenoate.
    Liang H; Zhong Y; Zhou S; Li QQ
    In Vivo; 2011; 25(5):711-8. PubMed ID: 21753123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.
    Sheng X; Wang M; Lu M; Xi B; Sheng H; Zang YQ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E886-93. PubMed ID: 21364120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andrographolide prevents high-fat diet-induced obesity in C57BL/6 mice by suppressing the sterol regulatory element-binding protein pathway.
    Ding L; Li J; Song B; Xiao X; Huang W; Zhang B; Tang X; Qi M; Yang Q; Yang Q; Yang L; Wang Z
    J Pharmacol Exp Ther; 2014 Nov; 351(2):474-83. PubMed ID: 25204338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11beta-HSD1, PEPCK and DGAT2. Comparison of PPARalpha, PPARgamma, and liver x receptor agonists.
    Srivastava RA
    Eur J Pharmacol; 2009 Apr; 607(1-3):258-63. PubMed ID: 19245804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.